NRXS
Neuraxis, INCCompany Information
- Company Name
- Neuraxis, INC
- CIK
- CIK0001933567
- Category
- <br>Emerging growth company
- Ticker: Exchange
- NRXS: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- NRXS
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-04-01
- Last sale
- 2025-07-01
- Shares purchased (TTM)
- 716,079
- Shares sold (TTM)
- 821,327
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,715,721
- Shares outstanding
- 12,119,822
- Ownership
- 22.41%
Earnings Market Reaction
- Filing date
- 2026-08-11
- Price on filing date
- —
- 1-month reaction
- -6.14%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 7 | 5 | 4 | 6 | 2 | 4 | 0 | 2 | 0 | 0 | 1 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 9 | 8 | 6 | 5 | 7 | 3 | 4 | 1 | 2 | 0 | 0 | 1 | ||||||
| Property Plant And Equipment Gross | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets Noncurrent | ||||||||||||||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Security Deposit | - | - | 0 | - | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Assets | 10 | 9 | 6 | 6 | 7 | 3 | 5 | 1 | 3 | 1 | 1 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Accrued Liabilities Current | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable To Bank Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | 5 | 1 | - | - | ||||||
| Notes Payable Current | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Deposits | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 8 | 4 | 2 | 2 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Liabilities Noncurrent | - | - | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 8 | 4 | 2 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 76 | 72 | 68 | 65 | 65 | 59 | 59 | 54 | 48 | 47 | 47 | 42 | ||||||
| Retained Earnings Accumulated Deficit | -70 | -66 | -65 | -63 | -61 | -59 | -57 | -55 | -54 | -51 | -49 | -43 | ||||||
| Stockholders Equity | 7 | 6 | 3 | 2 | 4 | 0 | 2 | -2 | -5 | -3 | -1 | -1 | ||||||
| Liabilities And Stockholders Equity | 10 | 9 | 6 | 6 | 7 | 3 | 5 | 1 | 3 | 1 | 1 | 1 | ||||||
| Unamortized Debt Issuance Expense | - | - | - | - | - | - | - | - | 0 | 0 | - | - | ||||||
| Allowance For Doubtful Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Inventory Raw Materials Net Of Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Debt Instrument Unamortized Discount Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | 1 | - | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | 4 | 4 | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | 4 | 4 | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 12 | 11 | 11 | 10 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 5 | ||||||
| Shares Outstanding | 12 | 11 | 11 | 10 | 10 | 7 | 7 | 7 | 7 | 7 | 7 | 5 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNeuraxis, INC (NRXS) — SEC Financial Statements & Analysis
Neuraxis, INC (NRXS) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Neuraxis, INC trades on NYSE as: NRXS. Neuraxis, INC (NRXS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11. Based on that filing, Neuraxis, INC carries a market cap of $88.60M, a P/E ratio of -10.45x, a P/B ratio of 13.15x, a P/S ratio of 16.67x, an enterprise value of $80.32M, and an EV/EBITDA multiple of -10.52x. On profitability, it posts a gross margin of 85.56%, an operating margin of -144.51%, a net margin of -159.42%, a Return on Equity (ROE) of -154.26%, and a Return on Assets (ROA) of -99.22%. Per share, it reports EPS of $-0.70, diluted EPS of $-0.70, free cash flow per share of $-0.46, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 65.22% year-over-year, net income growth of 14.84% year-over-year, and EPS growth of -19.26% year-over-year. On the balance sheet, it maintains a current ratio of 3.04x, a quick ratio of 2.83x, working capital of $6.32M, a debt-to-equity ratio of 0.48x, a debt ratio of 0.33, an interest coverage ratio of -73.67x, free cash flow of $-5.63M (TTM), and net debt of $-8.28M. Figures sourced from SEC EDGAR.
- Market Cap
- $88.60M
- P/E TTM
- -10.45x
- EPS TTM
- $-0.70
- P/B TTM
- 13.15x
- ROE TTM
- -154.26%
- ROA TTM
- -99.22%
- Debt To Equity
- 0.48x
- Free Cash Flow TTM
- $-5.63M
- Net Revenue TTM Growth 1Y
- 65.22%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Neuraxis, INC in?
Neuraxis, INC (NRXS) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does NRXS trade on?
Neuraxis, INC (NRXS) trades on the NYSE.
Where is Neuraxis, INC incorporated?
Neuraxis, INC is incorporated in DE.
When was Neuraxis, INC (NRXS)'s most recent SEC filing?
Neuraxis, INC (NRXS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-11.
What is NRXS's market cap?
Neuraxis, INC (NRXS) has a market capitalization of $88.60M as of 2026-06-30.
What is NRXS's EPS (earnings per share)?
Neuraxis, INC (NRXS)'s trailing twelve month EPS is $-0.70 as of 2026-06-30.
What is NRXS's ROE (return on equity)?
Neuraxis, INC (NRXS)'s trailing twelve month Return on Equity (ROE) is -154.26% as of 2026-06-30.
What is NRXS's ROA (return on assets)?
Neuraxis, INC (NRXS)'s trailing twelve month Return on Assets (ROA) is -99.22% as of 2026-06-30.
What is NRXS's EV/EBITDA?
Neuraxis, INC (NRXS)'s trailing twelve month EV/EBITDA is -10.52x as of 2026-06-30.